SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

An alleged leak of Phase 3 results for Modernas personalized melanoma vaccine with Merck has sparked a sharp selloff, with traders debating whether the reported benefit fell short of elevated expectations or whether the move reflects rumor-driven trading and manipulation. The datas significance remains disputed as investors await the full ESMO presentation.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A broad semiconductor and Nasdaq selloff has driven SOXL to a six-month low, with traders pointing to geopolitical tensions and higher oil, renewed concerns about AI financing, and weakness across chip stocks. The funds 3 daily leverage is intensifying the drop; the community is divided between buying the dip and warning that semiconductor weakness and leverage-related decay could bring further losses.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia shares sold off despite a quarterly earnings beat as traders focused on weaker free-cash-flow conversion guidance, negative cash flow, higher restructuring costs, and rising supply expenses. Bulls see the reaction as an overreaction and point to strong AI and cloud demand, while bears argue that cash generation and the cautious outlook matter more than the headline results.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

A sharp reversal after SpaceXs earnings pop is being attributed by traders mainly to a large insider share unlock, with concerns about added selling pressure compounded by valuation and capital-spending worries and a broader tech-market selloff. Bulls are treating the decline as a buying opportunity, while bears argue the earnings beat does not justify the valuation; Tesla-merger speculation is also part of the debate.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

A sharp selloff in SanDisk and other memory stocks is driving discussion, with traders citing concerns about Chinese competition, uncertainty around AI spending and broader semiconductor weakness; some also describe the decline as unexplained or blame market manipulation. Bulls are buying the dip ahead of earnings and point to AI-driven NAND demand, while bears warn that memory-sector pressure could persist.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

CFO Ryan Fiedlers departure has triggered a sharp selloff and debate over whether the move signals undisclosed financial problems or is an overreaction; some traders cite the qualified internal successor and strong backlog as reasons for confidence, while others want more clarity from management.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is under pressure as a broad tech and semiconductor selloff coincides with surging oil and Iran-related tensions, while renewed concerns about AI spending and fundingincluding comments on neocloud capital needsadd to risk-off sentiment. Traders are largely bearish and watching support, though some see the decline as a buying opportunity and expect a bounce.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

A sharp selloff in Intel shares, alongside weakness across semiconductor and AI stocks, dominates the discussion as traders weigh broad market pressure and uncertainty ahead of earnings. The community is split between calling the decline an oversold buying opportunity and warning that the sector downturn or Intels own risks could mean further downside; claims of deliberate shorting remain speculation.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Metas earnings beat and upbeat guidance were overshadowed by concerns about heavy AI infrastructure spending, negative free cash flow, and potential share dilution or outside financing. Traders are split between viewing the selloff as an overreaction and worrying that AI investment costs may outpace returns.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons rebound is being linked to Morgan Stanley naming it a top pick, alongside optimism about AWS growth and AI-related opportunities. Traders are cheering the upgrade but debating whether the gains can hold into the October 29 earnings report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?

Haemonetics (HAE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Cannabis Stock CRLBF Surges 10% in a Month: Time to Buy or Sell?

Cresco's 10% monthly rally reflects stronger revenues, organic growth and margins, but competition and normalization risks cloud the outlook.

Cresco Labs Inc. (CRLBF) Q2 Earnings and Revenues Top Estimates

Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of +300.00% and +4.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out?

Green Thumb has surged 17.5% in three months as regulatory progress, Q1 growth and buybacks lift sentiment, but competition and pricing pressure persist.

Cannabis Operator Cresco Down 28.5% YTD: How to Play the Stock?

CRLBF is down 28.5% YTD as revenue pressure and competition persist, but retail expansion and improving estimates could shape its next move.

MSOS Hits 2026 High: Which Cannabis Stock Could Light Up Portfolios Ahead Of DEA Hearing?

Equity

The cannabis ETF has surged 104% over the past year, outperforming both the North American Marijuana Index and the S&P 500.

Cresco Labs Inc. (CRLBF) Upgraded to Buy: Here's Why

Cresco Labs Inc. (CRLBF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cresco Labs Inc. (CRLBF) Reports Q1 Loss, Beats Revenue Estimates

Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of -33.33% and +1.81%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates

Maravai LifeSciences (MRVI) delivered earnings and revenue surprises of +121.41% and +20.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Why Fast-paced Mover Cresco Labs Inc. (CRLBF) Is a Great Choice for Value Investors

Cresco Labs Inc. (CRLBF) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.

Cresco Labs Inc. - Ordinary Shares (Sub Voting)

Bullish Sentiment

<ul class="summary-bullets"><li>Trulieve, MSOS' largest holding, is set to uplist to the NYSE on Wednesday after restructuring its business around medical cannabis operations.</li><li>The upcoming DEA hearing comes after April's Schedule III move for state-licensed medical marijuana, which removed key tax penalties.</li><li>AdvisorShares said that the rescheduling could boost earnings, cash flow, capital access, banking services and institutional participation across the sector.</li></ul><p>Shares of the AdvisorShares Pure US Cannabis ETF (MSOS) have hit their highest levels in 2026 as investors pile into cannabis stocks ahead of a regulatory hearing due later this month, with Trulieve's landmark NYSE listing adding fuel to the search for the sector's next big winner.</p><p>As of May 31,&nbsp;<a href="https://stocktwits.com/symbol/MSOS">MSOS</a> delivered a 103.7% one-year net asset value (NAV) return, outperforming the North American Marijuana Index's 36.9% gain and the S&amp;P 500's 29.8% return. The ETF has also gained 28% over the past three months, while the marijuana benchmark declined about 1%. As of June 5, MSOS managed $1.13 billion in assets.</p><p><img src="https://news.stocktwits-cdn.com/koyfin_20260609_091032612_png_534f3bee09.webp" alt="koyfin_20260609_091032612.png"></p><h2 class="st-heading-2"><strong>Trulieve Opens NYSE Door</strong></h2><p>Trulieve Cannabis, MSOS' largest holding at 30% of assets, said its shares would begin trading on the NYSE under the symbol TRLV from Wednesday. CEO Kim Rivers called the listing a "historic milestone" and said that the Trump administration's decision to reclassify medical marijuana to Schedule III helped pave the way for the approval.</p><div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col><col><col></colgroup><tbody><tr><td>Company</td><td>Weight</td><td>Price</td><td>PT</td><td>Upside</td></tr><tr><td>Trulieve (TCNNF)</td><td>30.2%</td><td>13</td><td>$16.45</td><td>27%</td></tr><tr><td>Curaleaf (CURLD)</td><td>26.3%</td><td>11.22</td><td>$12.71</td><td>13%</td></tr><tr><td>Green Thumb (GTBIF)</td><td>18.2%</td><td>8.74</td><td>$14.84</td><td>70%</td></tr><tr><td>Glass House (GLASF)</td><td>8.3%</td><td>$13.14</td><td>$10.25</td><td>-22%</td></tr><tr><td>Verano (VRNO)</td><td>5%</td><td>$1.21</td><td>$3.57</td><td>195%</td></tr><tr><td>Cresco (CRLBF)</td><td>4.4%</td><td>$0.95</td><td>$1.89</td><td>99%</td></tr><tr><td>TerrAscend (TSNDF)</td><td>4.2%</td><td>$0.77</td><td>$1.28</td><td>66%</td></tr><tr><td>Jushi (JUSHF)</td><td>1.6%</td><td>$0.53</td><td>$1.0</td><td>183%</td></tr></tbody></table></figure></div><p>The company recently separated its medical cannabis operations from adult-use businesses, allowing it to qualify for a senior U.S. exchange listing. Alliance Global, which maintains a 'Buy' rating and a C$27 price target on Trulieve, said the company is in a "unique" position given its concentration in medical-only states and its exposure to expanding medical markets such as Texas and Georgia.</p><h2 class="st-heading-2"><strong>Why The DEA Hearing Matters</strong></h2><p>The June 29 administrative hearing will examine whether broader marijuana products, including adult-use cannabis, should be moved to Schedule III. The proceeding is expected to run through no later than July 15.</p><p>Investor excitement has been building since April, when Acting Attorney General Todd Blanche moved state-licensed medical marijuana products into Schedule III and launched the process for broader rescheduling. The move eliminated tax penalties for licensed medical cannabis operators, allowing companies to deduct ordinary business expenses such as payroll, rent and interest. Adding to the bullish sentiment, U.S. President Donald Trump on Monday formally nominated Blanche to serve as attorney general permanently.</p><h2 class="st-heading-2"><strong>Cannabis Firms Eye Uplisting Opportunities</strong></h2><p>AdvisorShares said the change could boost earnings, free cash flow, and balance-sheet strength across the industry, while also improving access to capital, banking services, and institutional investors. Roth Capital called the rescheduling order "extremely favorable" for the cannabis sector, citing benefits for taxation, capital access, future uplistings and overall sector investability.&nbsp;</p><p>One of the benefits investors expected from Schedule III came on Monday when Cresco Labs secured a $50 million revolving credit facility from Needham Bank. CEO Charlie Bachtell said the financing provides a "powerful, non-dilutive tool" to fund acquisitions, while positioning the company for access to U.S. capital markets and a future uplisting to a senior exchange.&nbsp;</p><p>While not part of MSOS, Tilray Brands (TLRY) has also positioned itself for potential cannabis reform, saying it may use proceeds from its at-the-market program last month to pursue acquisitions and expansion.</p><h2 class="st-heading-2"><strong>Which MSOS Holding Offers The Biggest Upside?</strong></h2><p>While Trulieve has become the poster child for the industry's regulatory progress, several other MSOS holdings carry higher upside. Verano (VRNO) offers the highest upside at 195%, followed by Jushi Holdings (JUSHF) at 183% and Cresco Labs (CRLBF) at nearly 99%, according to Koyfin data.&nbsp;</p><p>Among MSOS' largest holdings, Green Thumb Industries (GTBIF), a U.S.- based retail company, stands out with a 70% upside, well above Trulieve Cannabis (TCNNF), the ETF's largest position, and Curaleaf Holdings (CURLF), the world's largest cannabis company by revenue.&nbsp;</p><h2 class="st-heading-2"><strong>How Do Retail Traders Feel About Cannabis Stocks?</strong></h2><p>On Stocktwits, sentiment for MSOS, TCNNF and GTBIF was 'extremely bullish' amid 'extremely high' message volume, while TLRY was 'extremely bullish' and CRLBF 'bullish', both on 'high' message volumes.&nbsp;</p><figure class="image"><img src="https://news.stocktwits-cdn.com/msos_ss_png_04cd84375d.webp" alt="msos ss.png" width="970" height="130"><figcaption>MSOS sentiment and message volume as of June 9 | Source: Stocktwits</figcaption></figure><p>One user&nbsp;<a href="https://stocktwits.com/thepalace2007/message/655819130">said</a>, “$MSOS buy the underlyings these 3 will uplist soon $GTBIF $TCNNF $CURLD.”</p><p><stembedurl>https://stocktwits.com/thepalace2007/message/655819130</stembedurl></p><p>Another user&nbsp;<a href="https://stocktwits.com/FreyBentos/message/655820037">said</a>, “$GTBIF and $TCNNF are the best two plays in the cannabis sector and the only two you need to own.”</p><p><stembedurl>https://stocktwits.com/FreyBentos/message/655820037</stembedurl></p><p>MSOS ETF has jumped 143% over the past year.&nbsp;</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p><p>Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/oscr-stock-5-year-high-healthy-tailwinds-2026/cZ0xDLpR7be">OSCR Stock Hits 5-Year High: Oscar Sees 'Healthy Tailwinds' In 2026 On Potential Upside To Guidance&nbsp;</a></p>

MSOS ETF has jumped 143% over the past year. (Photo credit: Getty Images)

Cresco Labs Inc

Green Thumb Industries

AdvisorShares Pure US Cannabis ETF

Tilray Brands Inc

Very bullish

Cautiously bullish

Cautiously bearish

Very bearish

Stocktwits sentiment on $SPY just hit its lowest level of the year. How are you feeling about the market right now?

Stocktwits

 just hit its lowest level of the year. How are you feeling about the market right now?

Current Price	$0.6258
Prev Close	$0.66
Open	$0.6599
Dividend Yield	0.00%
50-Day Moving Average	$0.7216
Beta	1.28
Avg. Volume	678,171.19
PE Ratio	-2.26

52-Week High	$2.30
52-Week Low	$0.5711
Market Capitalization	$245.75M
EPS (Annual)	-$0.3814
Price to Book	0.69
Revenue Per Employee	$226,154.14

Feed

News

Sentiment

Earnings

Fundamentals

Info

CRLBF Fundamentals